Over 41,000 bottles of Walgreens nasal spray are being recalled, raising concerns about product safety and consumer protection.
Story Highlights
- The FDA recalls 41,328 bottles of Walgreens nasal spray due to contamination risks.
- Contamination involves pseudomonas lactis, a bacterium found in raw milk.
- Recalled products include specific lots of Walgreens Saline Nasal Spray with Xylitol.
- A Class II recall indicates potential temporary health consequences.
FDA Issues Major Recall on Walgreens Nasal Spray
The FDA announced a significant recall of 41,328 bottles of Walgreens nasal spray in November 2025. The recall targets the 1.5-oz bottles of Walgreens Saline Nasal Spray with Xylitol. Concerns have arisen over potential contamination with pseudomonas lactis, a bacterium typically found in raw milk. This recall serves as a reminder of the need for rigorous quality control in consumer health products.
Authorities have issued the recall as a Class II alert, indicating that exposure could cause temporary or medically reversible adverse health consequences. The probability of serious health issues remains low, yet consumers are advised to exercise caution.
💊 CHECK YOUR CABINET: The FDA announced a recall of 41,000+ bottles of Walgreens Saline Nasal Spray with Xylitol over possible bacterial contamination.https://t.co/vHsbLtvj3F
— Fox News (@FoxNews) November 25, 2025
Consumer Safety Measures and Instructions
Walgreens has stressed the importance of consumer safety, urging customers with affected products to return them for a full refund. The recalled products are identified by lot numbers 71409 and 71861, with expiration dates in 2027. These sprays have been sold across Walgreens locations nationwide, necessitating widespread consumer awareness and action.
Despite the recall’s voluntary nature, it underscores the critical need for stringent safety protocols in manufacturing and distribution processes. Consumers are reminded to always check product safety alerts and recalls to prevent potential health risks.
Implications and Preventative Measures
This incident highlights ongoing challenges in ensuring product safety, particularly in health-related consumer goods. It calls into question the regulatory measures in place to protect consumers from similar issues. The Centers for Disease Control and Prevention (CDC) has also emphasized the importance of vaccinations to mitigate health risks during flu season, urging individuals to follow preventive guidelines such as regular handwashing and avoiding contact with sick individuals.
As the situation develops, it is crucial for consumers to stay informed and vigilant about product recalls and safety alerts.
